OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology MARTINSRIED, Germany, June 16, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment:TecDAX) announced today that U.S. based biopharmaceutical company OncoMed Pharmaceuticals, Inc....